| Dr Ashley Thurston Jenkins, MD | |
|
1 Mercy Ln, Suite 201, Hot Springs, AR 71913-6442 | |
| (501) 609-2222 | |
| (501) 321-9689 |
| Full Name | Dr Ashley Thurston Jenkins |
|---|---|
| Gender | Female |
| Speciality | Internal Medicine |
| Experience | 17 Years |
| Location | 1 Mercy Ln, Hot Springs, Arkansas |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1053756312 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208M00000X | Hospitalist | T2016-120 (Arkansas) | Primary |
| 207R00000X | Internal Medicine | T2016-120 (Arkansas) | Secondary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Arkansas Hospice Inc | North little rock, AR | Hospice |
| St Vincent Hot Springs | Hot springs, AR | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Chi St Vincent Medical Group Hot Springs | 3971673716 | 151 |
News Archive
MK 1775, a small, selective inhibitor molecule, has been found to be active against many sarcomas when tested by researchers at Moffitt Cancer Center in Tampa, Fla. Their findings, recently appearing in Molecular Cancer Therapeutics, published by the American Association for Cancer Research, suggest that a badly needed new agent against sarcomas - especially sarcomas affecting children - may be at hand.
Chronic sleep disruption during adolescence can lead to depression in both males and females and alters stress reactivity in females, according to a new study led by University of Ottawa researchers.
GeneGo, Inc., the leading systems biology tools company, announced today that Proteostasis Therapeutics has licensed its data mining and analysis platform, MetaCore. Proteostasis Therapeutics is the first company dedicated to the discovery of novel small molecule therapeutics based upon understanding the body's Proteostasis Network. The Proteostasis Network maintains the body's natural balance of proteins to protect us from numerous diseases.
In collaboration with Novo Biosciences, Inc., LSU Health New Orleans Cardiovascular Center of Excellence will receive more $500,000 over two years to study the effectiveness of a novel drug designed to stimulate the regeneration of heart muscle and prevent the formation or scar tissue following a heart attack.
› Verified 7 days ago
| Entity Name | Chi St Vincent Medical Group Hot Springs |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1831387117 PECOS PAC ID: 3971673716 Enrollment ID: O20080604000802 |
News Archive
MK 1775, a small, selective inhibitor molecule, has been found to be active against many sarcomas when tested by researchers at Moffitt Cancer Center in Tampa, Fla. Their findings, recently appearing in Molecular Cancer Therapeutics, published by the American Association for Cancer Research, suggest that a badly needed new agent against sarcomas - especially sarcomas affecting children - may be at hand.
Chronic sleep disruption during adolescence can lead to depression in both males and females and alters stress reactivity in females, according to a new study led by University of Ottawa researchers.
GeneGo, Inc., the leading systems biology tools company, announced today that Proteostasis Therapeutics has licensed its data mining and analysis platform, MetaCore. Proteostasis Therapeutics is the first company dedicated to the discovery of novel small molecule therapeutics based upon understanding the body's Proteostasis Network. The Proteostasis Network maintains the body's natural balance of proteins to protect us from numerous diseases.
In collaboration with Novo Biosciences, Inc., LSU Health New Orleans Cardiovascular Center of Excellence will receive more $500,000 over two years to study the effectiveness of a novel drug designed to stimulate the regeneration of heart muscle and prevent the formation or scar tissue following a heart attack.
› Verified 7 days ago
| Entity Name | Howard Memorial Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1467852210 PECOS PAC ID: 7315851599 Enrollment ID: O20150616002502 |
News Archive
MK 1775, a small, selective inhibitor molecule, has been found to be active against many sarcomas when tested by researchers at Moffitt Cancer Center in Tampa, Fla. Their findings, recently appearing in Molecular Cancer Therapeutics, published by the American Association for Cancer Research, suggest that a badly needed new agent against sarcomas - especially sarcomas affecting children - may be at hand.
Chronic sleep disruption during adolescence can lead to depression in both males and females and alters stress reactivity in females, according to a new study led by University of Ottawa researchers.
GeneGo, Inc., the leading systems biology tools company, announced today that Proteostasis Therapeutics has licensed its data mining and analysis platform, MetaCore. Proteostasis Therapeutics is the first company dedicated to the discovery of novel small molecule therapeutics based upon understanding the body's Proteostasis Network. The Proteostasis Network maintains the body's natural balance of proteins to protect us from numerous diseases.
In collaboration with Novo Biosciences, Inc., LSU Health New Orleans Cardiovascular Center of Excellence will receive more $500,000 over two years to study the effectiveness of a novel drug designed to stimulate the regeneration of heart muscle and prevent the formation or scar tissue following a heart attack.
› Verified 7 days ago
| Entity Name | Southeast Arkansas Hospitalists Llp |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1912374018 PECOS PAC ID: 9537479605 Enrollment ID: O20151103000750 |
News Archive
MK 1775, a small, selective inhibitor molecule, has been found to be active against many sarcomas when tested by researchers at Moffitt Cancer Center in Tampa, Fla. Their findings, recently appearing in Molecular Cancer Therapeutics, published by the American Association for Cancer Research, suggest that a badly needed new agent against sarcomas - especially sarcomas affecting children - may be at hand.
Chronic sleep disruption during adolescence can lead to depression in both males and females and alters stress reactivity in females, according to a new study led by University of Ottawa researchers.
GeneGo, Inc., the leading systems biology tools company, announced today that Proteostasis Therapeutics has licensed its data mining and analysis platform, MetaCore. Proteostasis Therapeutics is the first company dedicated to the discovery of novel small molecule therapeutics based upon understanding the body's Proteostasis Network. The Proteostasis Network maintains the body's natural balance of proteins to protect us from numerous diseases.
In collaboration with Novo Biosciences, Inc., LSU Health New Orleans Cardiovascular Center of Excellence will receive more $500,000 over two years to study the effectiveness of a novel drug designed to stimulate the regeneration of heart muscle and prevent the formation or scar tissue following a heart attack.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Ashley Thurston Jenkins, MD Po Box 21850, Hot Springs, AR 71903-1850 Ph: (501) 609-2222 | Dr Ashley Thurston Jenkins, MD 1 Mercy Ln, Suite 201, Hot Springs, AR 71913-6442 Ph: (501) 609-2222 |
News Archive
MK 1775, a small, selective inhibitor molecule, has been found to be active against many sarcomas when tested by researchers at Moffitt Cancer Center in Tampa, Fla. Their findings, recently appearing in Molecular Cancer Therapeutics, published by the American Association for Cancer Research, suggest that a badly needed new agent against sarcomas - especially sarcomas affecting children - may be at hand.
Chronic sleep disruption during adolescence can lead to depression in both males and females and alters stress reactivity in females, according to a new study led by University of Ottawa researchers.
GeneGo, Inc., the leading systems biology tools company, announced today that Proteostasis Therapeutics has licensed its data mining and analysis platform, MetaCore. Proteostasis Therapeutics is the first company dedicated to the discovery of novel small molecule therapeutics based upon understanding the body's Proteostasis Network. The Proteostasis Network maintains the body's natural balance of proteins to protect us from numerous diseases.
In collaboration with Novo Biosciences, Inc., LSU Health New Orleans Cardiovascular Center of Excellence will receive more $500,000 over two years to study the effectiveness of a novel drug designed to stimulate the regeneration of heart muscle and prevent the formation or scar tissue following a heart attack.
› Verified 7 days ago
Dr. Jeffrey H. Bordelon, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 1 Mercy Ln, Suite 201, Hot Springs, AR 71913 Phone: 501-609-2222 Fax: 501-321-9689 | |
Dr. Mohamed Attia, M.D. Hospitalist Medicare: Medicare Enrolled Practice Location: 1 Mercy Ln Ste 404, Hot Springs, AR 71913 Phone: 501-609-2222 Fax: 501-321-9689 | |
Junu Bhattarai, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 1 Mercy Ln, Suite 201, Hot Springs, AR 71913 Phone: 501-609-2222 Fax: 501-321-9689 | |
Subash Chandra Subedi, Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 1 Mercy Ln Ste 405, Hot Springs, AR 71913 Phone: 501-609-2222 Fax: 501-321-9689 | |
Shauna L Lucas, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 1 Mercy Ln, Suite 201, Hot Springs, AR 71913 Phone: 501-609-2222 Fax: 501-321-9689 | |
Mian Adnan Waheed, M.D. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 1 Mercy Ln, Suite 201, Hot Springs, AR 71913 Phone: 501-609-2222 Fax: 501-321-9689 |